
TY  - JOUR
AU  - Haas, M.
AU  - Sis, B.
AU  - Racusen, L. C.
AU  - Solez, K.
AU  - Glotz, D.
AU  - Colvin, R. B.
AU  - Castro, M. C. R.
AU  - David, D. S. R.
AU  - David-Neto, E.
AU  - Bagnasco, S. M.
AU  - Cendales, L. C.
AU  - Cornell, L. D.
AU  - Demetris, A. J.
AU  - Drachenberg, C. B.
AU  - Farver, C. F.
AU  - Farris III, A. B.
AU  - Gibson, I. W.
AU  - Kraus, E.
AU  - Liapis, H.
AU  - Loupy, A.
AU  - Nickeleit, V.
AU  - Randhawa, P.
AU  - Rodriguez, E. R.
AU  - Rush, D.
AU  - Smith, R. N.
AU  - Tan, C. D.
AU  - Wallace, W. D.
AU  - Mengel, M.
AU  - as the Banff meeting report writing committee
TI  - Banff 2013 Meeting Report: Inclusion of C4d-Negative Antibody-Mediated Rejection and Antibody-Associated Arterial Lesions
JO  - American Journal of Transplantation
VL  - 14
IS  - 2
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12590
DO  - doi:10.1111/ajt.12590
SP  - 272
EP  - 283
KW  - Acute allograft rejection
KW  - antibody-mediated rejection
KW  - Banff schema
KW  - cardiac allograft
KW  - chronic allograft rejection
KW  - complement C4d
KW  - composite tissue allograft
KW  - donor-specific antibodies
KW  - liver allograft
KW  - lung transplantation
KW  - pancreas allograft
KW  - renal transplantation
KW  - transplant biopsy
KW  - transplant glomerulopathy
KW  - transplant pathology
PY  - 2014
AB  - The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from August 19?23, 2013, and was preceded by a 2-day Latin American Symposium on Transplant Immunobiology and Immunopathology. The meeting was highlighted by the presentation of the findings of several working groups formed at the 2009 and 2011 Banff meetings to: (1) establish consensus criteria for diagnosing antibody-mediated rejection (ABMR) in the presence and absence of detectable C4d deposition; (2) develop consensus definitions and thresholds for glomerulitis (g score) and chronic glomerulopathy (cg score), associated with improved inter-observer agreement and correlation with clinical, molecular and serological data; (3) determine whether isolated lesions of intimal arteritis (?isolated v?) represent acute rejection similar to intimal arteritis in the presence of tubulointerstitial inflammation; (4) compare different methodologies for evaluating interstitial fibrosis and for performing/evaluating implantation biopsies of renal allografts with regard to reproducibility and prediction of subsequent graft function; and (5) define clinically and prognostically significant morphologic criteria for subclassifying polyoma virus nephropathy. The key outcome of the 2013 conference is defining criteria for diagnosis of C4d-negative ABMR and respective modification of the Banff classification. In addition, three new Banff Working Groups were initiated.
ER  - 

TY  - JOUR
TI  - 22nd IEC Proceedings
JO  - Epilepsia
VL  - 38
IS  - s3
SN  - 0013-9580
UR  - https://doi.org/10.1111/j.1528-1157.1997.tb02952.x
DO  - doi:10.1111/j.1528-1157.1997.tb02952.x
SP  - 1
EP  - 284
PY  - 1997
ER  - 

TY  - JOUR
TI  - 17th International Congress of Immunology, 19–23 October 2019, Beijing, China
JO  - European Journal of Immunology
JA  - Eur. J. Immunol.
VL  - 49
IS  - S3
SN  - 0014-2980
UR  - https://doi.org/10.1002/eji.201970400
DO  - doi:10.1002/eji.201970400
SP  - 1
EP  - 2223
PY  - 2019
ER  - 

TY  - JOUR
TI  - Oral and Poster Presentations
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 77
IS  - S1
SN  - 1522-1946
UR  - https://doi.org/10.1002/ccd.23089
DO  - doi:10.1002/ccd.23089
SP  - S1
EP  - S156
PY  - 2011
ER  - 

TY  - JOUR
AU  - Ling, Josef
AU  - Merideth, Flannery
AU  - Caprihan, Arvind
AU  - Pena, Amanda
AU  - Teshiba, Terri
AU  - Mayer, Andrew R.
TI  - Head injury or head motion? Assessment and quantification of motion artifacts in diffusion tensor imaging studies
JO  - Human Brain Mapping
JA  - Hum. Brain Mapp.
VL  - 33
IS  - 1
SN  - 1065-9471
UR  - https://doi.org/10.1002/hbm.21192
DO  - doi:10.1002/hbm.21192
SP  - 50
EP  - 62
KW  - mild TBI
KW  - DTI
KW  - diffusion tensor imaging
KW  - gradient sampling schemes
KW  - motion
KW  - simulations
PY  - 2012
AB  - Abstract The relationship between head motion and diffusion values such as fractional anisotropy (FA) and mean diffusivity (MD) is currently not well understood. Simulation studies suggest that head motion may introduce either a positive or negative bias, but this has not been quantified in clinical studies. Moreover, alternative measures for removing bias as result of head motion, such as the removal of problematic gradients, has been suggested but not carefully evaluated. The current study examined the impact of head motion on FA and MD across three common pipelines (tract-based spatial statistics, voxelwise, and region of interest analyses) and determined the impact of removing diffusion weighted images. Our findings from a large cohort of healthy controls indicate that while head motion was associated with a positive bias for both FA and MD, the effect was greater for MD. The positive bias was observed across all three analysis pipelines and was present following established protocols for data processing, suggesting that current techniques (i.e., correction of both image and gradient table) for removing motion bias are likely insufficient. However, the removal of images with gross artifacts did not fundamentally change the relationship between motion and DTI scalar values. In addition, Monte Carlo simulations suggested that the random removal of images increases the bias and reduces the precision of both FA and MD. Finally, we provide an example of how head motion can be quantified across different neuropsychiatric populations, which should be implemented as part of any diffusion tensor imaging quality assurance protocol. Hum Brain Mapp, 2012. ? 2011 Wiley Periodicals, Inc.
ER  - 

TY  - JOUR
AU  - Krishnan, Kartik R.
AU  - Bhattacharya, Renuka
AU  - Pereira, Arema
AU  - Otto, Annie K.
AU  - Carithers Jr, Robert L.
AU  - Reyes, Jorge D.
AU  - Perkins, James D.
TI  - The HALOS-ND model: a step in the journey of predicting hospital length of stay after liver transplantation
JO  - Clinical Transplantation
JA  - Clin Transplant
VL  - 27
IS  - 6
SN  - 0902-0063
UR  - https://doi.org/10.1111/ctr.12217
DO  - doi:10.1111/ctr.12217
SP  - 809
EP  - 822
KW  - length of stay
KW  - predictive models
KW  - quality
KW  - risk
KW  - transplant cost
PY  - 2013
AB  - Abstract Hospital length of stay (LOS) after liver transplantation has been determined to correlate with liver disease severity, post-transplant survival rates, and transplant-associated costs. A patient's model for end-stage liver disease (MELD) score and an organ's Donor risk index (DRI) have both been found to be significant predictors of LOS, but these two factors alone are insufficient to form an accurate prediction. Previous studies have identified other factors predictive of LOS, which can be incorporated with MELD and DRI to create more specific results. The objective of this study was to create an algorithm, or models, based on the most significant LOS predictors as identified from national data at different stages of the transplant process. Four models were developed predicting LOS using recipient factors, payment factors, donor factors, and postoperative factors. A medical care team member can enter a patient's data into the model and receive a reasonably accurate prediction of LOS for each phase of the liver transplant process, specifying the impact of each factor. These predictions would help predict the factors most likely to prolong LOS, inform resource allocation, and provide patients with more specific predictions of their LOS following transplantation.
ER  - 

TY  - JOUR
TI  - PARKINSONISM I
JO  - Movement Disorders
VL  - 11
IS  - S1
SN  - 0885-3185
UR  - https://doi.org/10.1002/mds.1996.11.s1.113
DO  - doi:10.1002/mds.1996.11.s1.113
SP  - 113
EP  - 148
PY  - 1996
ER  - 

TY  - JOUR
TI  - Abstracts of the 6th Cachexia Conference, Milan, Italy, December 8–10, 2011
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - J Cachexia Sarcopenia Muscle
VL  - 2
IS  - 4
SN  - 2190-5991
UR  - https://doi.org/10.1007/s13539-011-0045-3
DO  - doi:10.1007/s13539-011-0045-3
SP  - 209
EP  - 261
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Sessions: Liver
JO  - American Journal of Transplantation
VL  - 14
IS  - S3
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.12892
DO  - doi:10.1111/ajt.12892
SP  - 693
EP  - 799
PY  - 2014
ER  - 

TY  - JOUR
TI  - AASLD Abstracts
JO  - Hepatology
JA  - Hepatology
VL  - 56
IS  - S1
SN  - 0270-9139
UR  - https://doi.org/10.1002/hep.26040
DO  - doi:10.1002/hep.26040
SP  - 191A
EP  - 1144A
PY  - 2012
ER  - 

TY  - JOUR
TI  - Absracts
JO  - Vox Sanguinis
VL  - 83
IS  - S2
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2002.tb05391.x
DO  - doi:10.1111/j.1423-0410.2002.tb05391.x
SP  - 1
EP  - 236
PY  - 2002
ER  - 

TY  - JOUR
TI  - Scientific Section
JO  - Transfusion
VL  - 44
IS  - s1
SN  - 0041-1132
UR  - https://doi.org/10.1111/j.0041-1132.2004.449_5.x
DO  - doi:10.1111/j.0041-1132.2004.449_5.x
SP  - 1A
EP  - 141A
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstract Supplement 2018 ACR/ARHP Annual Meeting
JO  - Arthritis & Rheumatology
JA  - Arthritis Rheumatol
VL  - 70
IS  - S9
SN  - 2326-5191
UR  - https://doi.org/10.1002/art.40700
DO  - doi:10.1002/art.40700
SP  - 1
EP  - 3584
PY  - 2018
AB  - Abstract For a searchable version of these abstracts, please visit www.acrabstracts.org.
ER  - 

TY  - JOUR
TI  - Abstracts of the 8th Annual Meeting of the Societe Francaise de Pharmacologie, Strasbourg, 26-28 April 2004
JO  - Fundamental & Clinical Pharmacology
VL  - 18
IS  - 2
SN  - 0767-3981
UR  - https://doi.org/10.1111/j.1472-8206.2004.00250.x
DO  - doi:10.1111/j.1472-8206.2004.00250.x
SP  - 215
EP  - 268
PY  - 2004
ER  - 

TY  - JOUR
TI  - Abstracts cont.
JO  - Clinical Microbiology and Infection
VL  - 11
IS  - s2
SN  - 1198-743X
UR  - https://doi.org/10.1111/j.1469-0691.2005.01135.x
DO  - doi:10.1111/j.1469-0691.2005.01135.x
SP  - 648
EP  - 744
PY  - 2005
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Journal of Gastroenterology and Hepatology
JA  - J Gastroenterol Hepatol
VL  - 28
IS  - S3
SN  - 0815-9319
UR  - https://doi.org/10.1111/jgh.12363_2
DO  - doi:10.1111/jgh.12363_2
SP  - 23
EP  - 693
PY  - 2013
ER  - 

TY  - JOUR
TI  - INVITED SPEAKER AND ORAL PRESENTATIONS
JO  - Xenotransplantation
VL  - 14
IS  - 5
SN  - 0908-665X
UR  - https://doi.org/10.1111/j.1399-3089.2007.00426.x
DO  - doi:10.1111/j.1399-3089.2007.00426.x
SP  - 375
EP  - 448
PY  - 2007
ER  - 

TY  - JOUR
TI  - Abstracts From the American Society for Apheresis 27th Annual Meeting, May 23-26, 2006 Las Vegas, Nevada
JO  - Journal of Clinical Apheresis
JA  - J. Clin. Apheresis
VL  - 21
IS  - 1
SN  - 0733-2459
UR  - https://doi.org/10.1002/jca.20098
DO  - doi:10.1002/jca.20098
SP  - 1
EP  - 48
PY  - 2006
ER  - 

TY  - JOUR
TI  - 2005 Congress exhibitors' product listings
JO  - AORN Journal
JA  - AORN Journal
VL  - 81
IS  - 1
SN  - 0001-2092
UR  - https://doi.org/10.1016/S0001-2092(06)60064-1
DO  - doi:10.1016/S0001-2092(06)60064-1
SP  - 99
EP  - 118
PY  - 2005
ER  - 

TY  - JOUR
TI  - Posters
JO  - European Journal of Clinical Investigation
JA  - Eur J Clin Invest
VL  - 49
IS  - S1
SN  - 0014-2972
UR  - https://doi.org/10.1111/eci.13109
DO  - doi:10.1111/eci.13109
SP  - 101
EP  - 221
PY  - 2019
ER  - 
